Upstream Bio UPB SEC Filings

NASDAQ UPB
$6.09 +0.01 (+0.16%)
As of: Sep 4, 2026 · 11:49 AM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Upstream Bio, Inc. (UPB) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index